Leukemia Lymphoid
Mostrando 13-24 de 353 artigos, teses e dissertações.
-
13. T-cell/myeloid mixed-phenotype acute leukemia with monocytic differentiation and isolated 17p deletion
Mixed phenotype acute leukemia is a rare subtype of leukemia that probably arises from a hematopoietic pluripotent stem cell. The co-expression of two of myeloid, B- or T-lymphoid antigens is the hallmark of this disease. Herein, the case of a 28-year-old female patient is reported who presented with hemoglobin of 5.8 g/dL, white blood cell count of 138 × 1
Rev. Bras. Hematol. Hemoter.. Publicado em: 2014-07
-
14. The catechin flavonoid reduces proliferation and induces apoptosis of murine lymphoma cells LB02 through modulation of antiapoptotic proteins
Flavonoids are products of secondary metabolism of plants. They are present in herbs and trees and also act as natural chemopreventives and anticancer agents. Ligaria cuneifolia (Ruiz & Pav.) Tiegh., Loranthaceae, is a hemiparasite species that belongs to Argentine flora. Phytochemical studies have disclosed the presence of quercetin, catechin-4β-ol and pro
Rev. bras. farmacogn.. Publicado em: 26/03/2013
-
15. Intrachromosomal amplification of chromosome 21 (iAMP21) detected by ETV6/RUNX1 FISH screening in childhood acute lymphoblastic leukemia: a case report
Chromosome abnormalities that usually define high-risk acute lymphoblastic leukemia are the t(9;22)/ breakpoint cluster region protein-Abelson murine leukemia viral oncogene homolog 1, hypodiploid with < 44 chromosomes and 11q23/ myeloid/lymphoid leukemia gene rearrangements. The spectrum of acute lymphoblastic leukemia genetic abnormalities is nevertheless
Rev. Bras. Hematol. Hemoter.. Publicado em: 2013
-
16. Survival of patients diagnosed with subsets of lymphoid neoplasms and acute myeloid leukemia from 2000 to 2010 in the Vale do Paraíba, State of São Paulo: are we going the right way?
Revista Brasileira de Hematologia e Hemoterapia. Publicado em: 2012
-
17. Estudo da sobrevida média relativa em portadores de Leucemia Linfóide Aguda
O objetivo da pesquisa foi determinar a sobrevida média relativa de pacientes pediátricos e adolescentes portadores de leucemia linfóide aguda (LLA) tratados pelo protocolo do Grupo Brasileiro Cooperativo para Tratamento de Leucemia Linfocítica Aguda na Infância (GBLTI-LLA 99), no Hospital Regional de Mato Grosso do Sul Rosa Pedrossian. Realizou-se a pe
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 12/12/2011
-
18. Clinical applications of immunoglobulin: update
Human immunoglobulin is the most used blood product in the clinical practice. Immunoglobulin applications have increased quickly since the elucidation of its immunomodulatory and antiinflammatory properties which turned this blood product into a precious tool in the treatment of numerous diseases that present with humoral immune deficiency or that cause immu
Rev. Bras. Hematol. Hemoter.. Publicado em: 2011-06
-
19. Evaluation of anti-Wnt/β-catenin signaling agents by pGL4-TOP transfected stable cells with a luciferase reporter system
Refractory and relapsed leukemia is a major problem during cancer therapy, which is due to the aberrant activation of Wnt/β-catenin signaling pathway. Activation of this pathway is promoted by wingless (Wnt) proteins and induces co-activator β-catenin binding to lymphoid enhancer factor (LEF)/T-cell factor protein (TCF). To provide a convenient system for
Brazilian Journal of Medical and Biological Research. Publicado em: 2010-10
-
20. Identificação e estudo de genes diferencialmente expressos pelo estroma da medula ossea leucemica / Identification and study of genes differentially expressed by leukemic bone marrow stromal cells
A leucemia linfóide aguda (LLA) é a neoplasia mais freqüente na infância. As interações dos blastos da LLA com as células do estroma da medula óssea (MO) têm um impacto positivo na sobrevivência das células e resistência a quimioterapia. A LLA estimula as células do estroma da MO que reciprocamente promovem a sobrevivência da leucemia. Para ide
Publicado em: 2010
-
21. Avaliação da transfecção de células dendríticas com RNA tumoral como estratégia para indução de imunidade específica em pacientes com leucemia linfóide crônica. / Evaluation of dendritic cell transfection with tumor RNA as a strategy to induce specific immunity in chronic lymphoid leukemia patients.
O desenvolvimento da imunoterapia do câncer baseada em células dendríticas (DCs) é alvo de vários estudos. Para tumores sólidos, a abordagem baseada no uso de DCs alogenêicas fundidas com células tumorais tem se mostrado relativamente eficaz. Por outro lado, esta estratégia necessita uma massa tumoral considerável de cada paciente para a geração
Publicado em: 2010
-
22. Perfil ClÃnico e Laboratorial dos Pacientes com Leucemia Linfoide CrÃnica Atendidos no ServiÃo de Hematologia e Hemoterapiado HUWC-HEMOCE / Clinical and Laboratorial Profile of Patients with Chronic Lymphocytic Leukemia admitted at the hematology and hemotherapy service of the University Hospital Walter CantÃdio (HUWC) and Hemotherapy and Hematology Center of Cearà (HEMOCE).
A leucemia linfocÃtica crÃnica (LLC) à a leucemia mais freqÃente nos paÃses ocidentais, ocorrendo em cerca de 30% de todas as leucemias do adulto, acometendo principalmente a populaÃÃo acima de 65 anos de idade. à caracterizada pela proliferaÃÃo clonal de linfÃcitos tipo B CD5 positivos. Do ponto de vista epidemiolÃgico, raramente à vista entre
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 03/09/2009
-
23. Infrequent V617F mutation of the JAK2 gene in myeloid leukemia and its absence in lymphoid malignancies in Japan
A unique mutation of the JAK2 gene, V617F, has recently been identified in polycythemia vera, essential thrombocythemia and myeloid metaplasia with myelofibrosis. To determine the relevance of this mutation in other types of hematological neoplasms in Japan, we performed allele-specific polymerase chain reaction analysis on the JAK2 gene. The V617F mutation
Genetics and Molecular Biology. Publicado em: 2008
-
24. Methylenetetrahydrofolate reductase polymorphisms in myeloid leukemia patients from Northeastern Brazil
Methylenetetrahydrofolate reductase (MTHFR: EC 1.5.1.20) polymorphisms are associated to acute lymphoid leukemia in different populations. We used the polymerase chain reaction and the restriction fragment length polymorphism method (PCR-RFLP) to investigate MTHFR C677T and A1298C polymorphism frequencies in 67 patients with chronic myeloid leukemia (CML), 2
Genetics and Molecular Biology. Publicado em: 2008